EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms

Javid Moslehi, Andrew H Lichtman, Arlene H Sharpe, Lorenzo Galluzzi, Richard N Kitsis

Journal of Clinical Investigation · 01.03.2021 · 131 (5)

DOI: 10.1172/jci145186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.03.2021. Verfasst von Javid Moslehi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine and Division of Oncology, Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, …. Die Arbeit wurde bisher 230-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHumansImmune Checkpoint InhibitorsMyocarditis

Substanzen

BiomarkersImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine and Division of Oncology, Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Immunology and Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Radiation Oncology, Sandra and Edward Meyer Cancer Center, Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021). Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms. Journal of Clinical Investigation, 131(5). https://doi.org/10.1172/jci145186

Vancouver

Moslehi J, Lichtman AH, Sharpe AH, Galluzzi L, Kitsis RN. Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms. Journal of Clinical Investigation. 2021;131(5). doi:10.1172/jci145186

BibTeX
@article{Moslehi2021,
  author = {Moslehi, Javid and Lichtman, Andrew H and Sharpe, Arlene H and Galluzzi, Lorenzo and Kitsis, Richard N},
  title = {Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {5},
  doi = {10.1172/jci145186}
}
Kostenlos starten →